NIH-funded research R01 grant

Brainstem autonomic centers and their control of nerves to muscles in age-related muscle loss

Official title: Role of Central Autonomic Relays in Aging Sarcopenia

Funded at Wake Forest University Health Sciences · NIH-11251637 · Data updated 2026-11-12

This research looks at whether changes in brain autonomic centers and the sympathetic nerves that talk to muscles contribute to muscle loss and weakness in older adults.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWake Forest University Health Sciences
NIH-funded
Lab location1 site (Winston-Salem, United States)
Project startFebruary 15, 2022
Project endJanuary 31, 2027
Funding year2026
Award (this year)$581,796
NIH project number5R01AG071545-05
Project IDNIH-11251637 on NIH RePORTER

Who could benefit from this research

Could help

Older adults experiencing age-related muscle loss or weakness, and people with neurodegenerative conditions that cause impaired autonomic or motor function, would be the most relevant group for this work.

Less likely to help

People whose muscle loss is primarily caused by acute injury, disuse without autonomic involvement, or purely metabolic causes may not directly benefit from these specific findings.

What this research studies

From a patient's perspective, the team is studying how a brainstem region (the pontine A5 nucleus) and the sympathetic nervous system help keep muscle fibers and the nerve-muscle connection healthy as we age. They use laboratory models to change activity in these central autonomic relays and in peripheral sympathetic nerves, and then measure muscle mass, strength, nerve connections at the neuromuscular junction, and molecular signals like adrenergic receptors and calcium channels. The researchers combine genetic tools, drugs that mimic or block sympathetic signaling, and cellular and physiological measurements to see which pathways fail with aging. The goal is to pinpoint specific nerve and molecular changes that could be targeted to prevent or slow sarcopenia.

Why it matters

Potential benefit: If successful, this work could point to new ways to preserve muscle mass and strength in older adults by targeting autonomic nerve signaling.

How similar studies have gone: Previous animal studies have shown that sympathetic nerves influence neuromuscular junctions and that this effect declines with age, but translating these findings into human treatments remains largely untested.

Where this research is happening

  • Wake Forest University Health Sciences
    Winston-Salem, United States
    Active

Researchers

  • Principal investigator: Delbono, Osvaldo — Wake Forest University Health Sciences
  • Study coordinator: Delbono, Osvaldo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.